Holen Sie sich die Stockscreener-App
2.36
16.26%
0.33
Handel nachbörslich:
2.29
-0.07
-2.97%
Schlusskurs vom Vortag:
$2.03
Offen:
$2.03
24-Stunden-Volumen:
939.44K
Relative Volume:
1.39
Marktkapitalisierung:
$166.92M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.5733
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+4.19%
1M Leistung:
-25.79%
6M Leistung:
-36.90%
1J Leistung:
-69.19%
1-Tages-Spanne:
$2.03
$2.405
1-Wochen-Bereich:
$2.015
$2.405
52-Wochen-Spanne:
$2.015
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.36 | 143.58M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
244.06 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
70.29 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.91 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.42 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.74 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Can Health Catalyst Inc. (2YP) stock hold up in economic slowdownQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Health Catalyst Inc. (2YP) stock gain from lower interest rates - newser.com
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know - The Globe and Mail
Why Health Catalyst Inc. stock could outperform in 2025Breakout Watch & Capital Efficient Trade Techniques - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumWeekly Investment Summary & Free High Return Stock Watch Alerts - newser.com
Identifying reversal signals in Health Catalyst Inc.July 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Is Health Catalyst Inc. (2YP) stock good for wealth creation2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - TradingView
Building trade automation scripts for Health Catalyst Inc.Trade Ideas & Safe Capital Preservation Plans - newser.com
Is Health Catalyst Inc. still worth holding after the dipEarnings Growth Summary & Community Verified Watchlist Alerts - newser.com
5 Revealing Analyst Questions From Health Catalyst's Q3 Earnings Call - Finviz
Health Catalysts Q3 2025 Results: Revenue Beat, Stable Performance & 2026 OutlookNews and Statistics - IndexBox
5 Revealing Analyst Questions From Health Catalyst’s Q3 Earnings Call - The Globe and Mail
Can machine learning forecast Health Catalyst Inc. recoveryEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Live market analysis of Health Catalyst Inc.July 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Health Catalyst, Inc. $HCAT Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
How to build a dashboard for Health Catalyst Inc. stockPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
Why Health Catalyst Inc. stock could benefit from AI revolutionTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Quantitative breakdown of Health Catalyst Inc. recent move2025 Market Sentiment & Weekly Stock Breakout Alerts - newser.com
Little Excitement Around Health Catalyst, Inc.'s (NASDAQ:HCAT) Revenues As Shares Take 26% Pounding - 富途牛牛
Acadian Asset Management LLC Has $4.39 Million Stake in Health Catalyst, Inc. $HCAT - MarketBeat
Can Health Catalyst Inc. stock beat market expectations this quarterEntry Point & High Return Trade Guides - newser.com
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.42%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):